E Sarvary

Summary

Publications

  1. doi request reprint Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off level
    E Sarvary
    Semmelweis Medical University, Transplantation and Surgical Clinic, Budapest, Hungary
    Transplant Proc 44:2157-61. 2012
  2. doi request reprint Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantation
    E Sarvary
    Semmelweis Medical University, Transplantation and Surgical Clinic Budapest, Budapest, Hungary
    Transplant Proc 42:2317-22. 2010
  3. doi request reprint The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program
    B Nemes
    Clinic of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
    Transplant Proc 43:1272-4. 2011
  4. doi request reprint Predictive factors of sustained virological response for recurrent hepatitis C virus after liver transplantation: the hungarian experience
    B Nemes
    Clinic of Transplantation and Surgery, Semmelweis University Budapest, Budapest, Hungary
    Transplant Proc 44:2162-3. 2012
  5. doi request reprint Measurement and clinical significance of interleukin 28B in hepatitis C virus-infected liver transplant patients
    Z Gerlei
    Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
    Transplant Proc 44:2154-6. 2012
  6. ncbi request reprint Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience
    M Varga
    Transplantation and Surgical Clinic, Faculty of General Medicine, Semmelweis University, Budapest, Hungary
    Transpl Infect Dis 7:63-7. 2005
  7. doi request reprint Can a cutoff value for cystatin C in the operative setting be determined to predict kidney function after liver transplantation?
    B Nemes
    Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
    Transplant Proc 42:2323-6. 2010
  8. doi request reprint Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis
    G Zádori
    Clinic of Transplantation and Surgery Budapest, Budapest, Hungary
    Transplant Proc 43:1267-71. 2011
  9. ncbi request reprint Prediction of early renal graft function by the measurement of donor urinary glutathione S-transferases
    E Sarvary
    Department of Transplantation and Surgery, Semmelweis University of Medicine, Budapest, Hungary
    Transplantation 69:1397-402. 2000
  10. ncbi request reprint Factors in association with sepsis after liver transplantation: the Hungarian experience
    B Nemes
    Transplantation and Surgical Clinic, Semmelweis University Budapest, Baross u 23, Budapest H 1087, Hungary
    Transplant Proc 37:2227-8. 2005

Collaborators

Detail Information

Publications12

  1. doi request reprint Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off level
    E Sarvary
    Semmelweis Medical University, Transplantation and Surgical Clinic, Budapest, Hungary
    Transplant Proc 44:2157-61. 2012
    ....
  2. doi request reprint Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantation
    E Sarvary
    Semmelweis Medical University, Transplantation and Surgical Clinic Budapest, Budapest, Hungary
    Transplant Proc 42:2317-22. 2010
    ..In conclusion substantial interlaboratory differences in MELD score have profound clinical consequences...
  3. doi request reprint The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program
    B Nemes
    Clinic of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
    Transplant Proc 43:1272-4. 2011
    ..The majority of cases who exceeded the Milan criteria had been transplanted before 2003. Our results suggested that the Milan criteria should be applied for the selection of candidates in order to promise good survival after OLT for HCC...
  4. doi request reprint Predictive factors of sustained virological response for recurrent hepatitis C virus after liver transplantation: the hungarian experience
    B Nemes
    Clinic of Transplantation and Surgery, Semmelweis University Budapest, Budapest, Hungary
    Transplant Proc 44:2162-3. 2012
    ..The 1- and 3-year cumulative patient survival rates trended to be better in cases of SVR compared with nonresponders (100% and 100% versus 94% and 89%; P = .07)...
  5. doi request reprint Measurement and clinical significance of interleukin 28B in hepatitis C virus-infected liver transplant patients
    Z Gerlei
    Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
    Transplant Proc 44:2154-6. 2012
    ..IL28B is just one predictive factor among others for successful posttransplant HCV therapy; further examinations are needed to fully understand its role...
  6. ncbi request reprint Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience
    M Varga
    Transplantation and Surgical Clinic, Faculty of General Medicine, Semmelweis University, Budapest, Hungary
    Transpl Infect Dis 7:63-7. 2005
    ..Cytomegalovirus (CMV) presents a serious threat to CMV-seronegative recipients (R-), who have received an organ from a seropositive donor (D+)...
  7. doi request reprint Can a cutoff value for cystatin C in the operative setting be determined to predict kidney function after liver transplantation?
    B Nemes
    Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
    Transplant Proc 42:2323-6. 2010
    ..Along with other researchers, we suggest that cystatin C is a sensitive marker of post-OLT kidney function...
  8. doi request reprint Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis
    G Zádori
    Clinic of Transplantation and Surgery Budapest, Budapest, Hungary
    Transplant Proc 43:1267-71. 2011
    ..756 ± 0.249 versus 1.304 ± 0.28 (P=.012). There was also a strong positive correlation between CLDN-1 protein expression and liver fibrosis (Pearson correlation coefficients: r=0.476; P=.034)...
  9. ncbi request reprint Prediction of early renal graft function by the measurement of donor urinary glutathione S-transferases
    E Sarvary
    Department of Transplantation and Surgery, Semmelweis University of Medicine, Budapest, Hungary
    Transplantation 69:1397-402. 2000
    ..We have investigated the possibility of urinary alpha- and pi class glutathione S-transferases (GST-a; GST-pi) serving as a valuable parameter to predict early graft function after transplantation...
  10. ncbi request reprint Factors in association with sepsis after liver transplantation: the Hungarian experience
    B Nemes
    Transplantation and Surgical Clinic, Semmelweis University Budapest, Baross u 23, Budapest H 1087, Hungary
    Transplant Proc 37:2227-8. 2005
    ..Our results agree with the international experience. A high amount of starch infusion and an extended use of broad spectrum antibiotics for prophylaxis adverse experiences in our center and have been removed from the protocol...
  11. doi request reprint Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group
    M Varga
    Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
    Transplant Proc 43:1233-5. 2011
    ..This information is important for calculating risk-factors for CMV-seronegative recipients. No nationwide estimates of CMV seroprevalence in Hungary (as a representative of Eastern Middle Europe) have been published yet...
  12. ncbi request reprint Mutation scanning of the p53 tumor suppressor gene in renal and liver transplant patients in Hungary
    E Sarvary
    Semmelweis University, Transplantation and Surgical Clinic, Budapest, Hungary
    Transplant Proc 37:969-72. 2005
    ..An earlier diagnosis can help to develop new strategies for immunosuppressive therapies...